268 related articles for article (PubMed ID: 33709190)
21. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q
Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587
[TBL] [Abstract][Full Text] [Related]
22. Immune infiltration profiling in gastric cancer and their clinical implications.
Ren F; Zhao Q; Zhao M; Zhu S; Liu B; Bukhari I; Zhang K; Wu W; Fu Y; Yu Y; Tang Y; Zheng P; Mi Y
Cancer Sci; 2021 Sep; 112(9):3569-3584. PubMed ID: 34251747
[TBL] [Abstract][Full Text] [Related]
23. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
24. CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors.
Rosenblum JM; Shimoda N; Schenk AD; Zhang H; Kish DD; Keslar K; Farber JM; Fairchild RL
J Immunol; 2010 Apr; 184(7):3450-60. PubMed ID: 20194716
[TBL] [Abstract][Full Text] [Related]
25. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4
Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q
Front Immunol; 2018; 9():2932. PubMed ID: 30619292
[TBL] [Abstract][Full Text] [Related]
26. Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.
Satooka H; Ishigaki H; Todo K; Terada K; Agata Y; Itoh Y; Ogasawara K; Hirata T
Sci Rep; 2020 May; 10(1):8414. PubMed ID: 32439888
[TBL] [Abstract][Full Text] [Related]
27. CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.
Villarroel VA; Okiyama N; Tsuji G; Linton JT; Katz SI
J Invest Dermatol; 2014 Jun; 134(6):1552-1560. PubMed ID: 24390137
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APC
Akeus P; Szeponik L; Ahlmanner F; Sundström P; Alsén S; Gustavsson B; Sparwasser T; Raghavan S; Quiding-Järbrink M
Cancer Immunol Immunother; 2018 Jul; 67(7):1067-1077. PubMed ID: 29671006
[TBL] [Abstract][Full Text] [Related]
29. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
30. EBV-positive pyothorax-associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3.
Higuchi T; Hashida Y; Matsuo K; Kitahata K; Ujihara T; Murakami I; Nakayama T; Daibata M
Cancer Sci; 2023 Jun; 114(6):2622-2633. PubMed ID: 36898851
[TBL] [Abstract][Full Text] [Related]
31. LINC00152 down-regulated
Huang Y; Luo H; Li F; Yang Y; Ou G; Ye X; Li N
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29339419
[TBL] [Abstract][Full Text] [Related]
32. CXCR3/CXCL10 Axis Shapes Tissue Distribution of Memory Phenotype CD8
Alanio C; Barreira da Silva R; Michonneau D; Bousso P; Ingersoll MA; Albert ML
J Immunol; 2018 Jan; 200(1):139-146. PubMed ID: 29187588
[TBL] [Abstract][Full Text] [Related]
33. Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.
Bronger H; Kraeft S; Schwarz-Boeger U; Cerny C; Stöckel A; Avril S; Kiechle M; Schmitt M
Breast Cancer Res; 2012 Feb; 14(1):R30. PubMed ID: 22333315
[TBL] [Abstract][Full Text] [Related]
34. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY
Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856
[TBL] [Abstract][Full Text] [Related]
35. Exercise Training Improves Tumor Control by Increasing CD8
Gomes-Santos IL; Amoozgar Z; Kumar AS; Ho WW; Roh K; Talele NP; Curtis H; Kawaguchi K; Jain RK; Fukumura D
Cancer Immunol Res; 2021 Jul; 9(7):765-778. PubMed ID: 33839688
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.
Peng D; Kryczek I; Nagarsheth N; Zhao L; Wei S; Wang W; Sun Y; Zhao E; Vatan L; Szeliga W; Kotarski J; Tarkowski R; Dou Y; Cho K; Hensley-Alford S; Munkarah A; Liu R; Zou W
Nature; 2015 Nov; 527(7577):249-53. PubMed ID: 26503055
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of Allergic Pulmonary Inflammation in CXCR3Knockout Mice Sensitized and Challenged with House Dust Mite Protein.
Liu Z; Chen H; Chen X; Gao J; Guo Z
PLoS One; 2016; 11(10):e0162905. PubMed ID: 27727269
[TBL] [Abstract][Full Text] [Related]
38. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
39. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration.
Zhang K; Zhang L; Mi Y; Tang Y; Ren F; Liu B; Zhang Y; Zheng P
Cancer Sci; 2020 Nov; 111(11):4041-4050. PubMed ID: 32860283
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
